A double blind trial compared clomipramine to placebo in the treatment of nine phobic patients for a period of six weeks. Overall, patients on clomipramine showed a larger decrease in phobic symptoms than did patients on placebo. Differences in improvement reached statistical significance only at Day 14 and favored clomipramine over placebo. It was the clinical impression that clomipramine has a positive therapeutic effect on patients with phobic neurosis. However, because of the small sample size, further controlled studies are needed to obtain decisive conclusions.
|Original language||English (US)|
|Number of pages||6|
|Journal||Current Therapeutic Research - Clinical and Experimental|
|State||Published - Dec 1 1976|
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)